• Title of article

    Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders

  • Author/Authors

    Ostovar, Afshin The Persian Gulf Tropical Medicine Research Center - Bushehr University of Medical Sciences , Haerinejad, Mohammad Javad The Persian Gulf Tropical Medicine Research Center - Bushehr University of Medical Sciences , Akbarzadeh, Samad Department of Biochemistry - Bushehr University of Medical Sciences , Keshavarz, Mojtaba Shiraz Neuroscience Research Center - Shiraz University of Medical Sciences

  • Pages
    6
  • From page
    220
  • To page
    225
  • Abstract
    Objective: The present study aimed at comparing the prevalence of major psychiatric disorders including major depressive disorder, bipolar disorder, schizophrenia, and generalized anxiety disorder between performance-enhancing drug users and nonuser bodybuilders. Moreover, the prevalence of major psychiatric disorders in bodybuilders was also reported. Method: In this study, 453 athletes were recruited from Bushehr bodybuilding gyms from February to May 2015. A structured questionnaire was used to collect the participants’ information, including demographic characteristics, sports’ status and performance-enhancing drug use. According to the condition of performance-enhancing drug use, the participants were divided into current users, non-current users, and nonusers. The psychiatric status of the participants was evaluated using DSM-IV diagnostic criteria for major depressive disorder, bipolar disorder, generalized anxiety disorder, and schizophrenia. We also asked about the acute psychotic disturbances after using performance-enhancing drugs, alcohol use, and history of aggressive behavior in bodybuilders. Data were analyzed using one-way analysis of variance and chi-square tests. Results: Prevalence of major depressive disorder, bipolar disorder, schizophrenia, generalized anxiety disorder, and the overall prevalence of psychiatric disorders in the bodybuilders was 19.7%, 3.8%, 1.5%, 16.6%, and 26.7%, respectively. After using performance-enhancing drugs, 33% of the bodybuilders had experienced acute psychological disturbances. There were no significant differences between current, non-current, and nonuser bodybuilding athletes in the measured psychiatric disorders. Conclusion: Prevalence of psychiatric disorders was not significantly different in performance-enhancing drug users and nonusers. Thus, it can be concluded that performance-enhancing drugs do not increase the risk of psychiatric disorders in bodybuilders.
  • Keywords
    Bodybuilder , Mental Disorders , Performance-Enhancing Drugs
  • Journal title
    Astroparticle Physics
  • Serial Year
    2017
  • Record number

    2420006